Nordin M J Hanssen (Nordin Mj Hanssen, Martin Teraa, N M J Hanssen)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Cardiovascular Risk Factors

Glycemic Control

Polycyclic Aromatic Hydrocarbons

Top Venues

Diabetes, obesity & metabolism

Diabetes & vascular disease research

This page only lists publications with an associated author ORCID identifier.

Publications

Coco M Fuhri Snethlage, Manon Balvers, Bart Ferwerda, Elena Rampanelli, Pleun de Groen, Bart O Roep, Hilde J Herrema, Timothy James McDonald, Daniel H van Raalte, Michael N Weedon, Richard D Oram, Max Nieuwdorp, Nordin M J Hanssen
Associations between diabetes-related genetic risk scores and residual beta cell function in type 1 diabetes: the GUTDM1 study. Diabetologia (2024)
Douwe F de Wit, Coco M Fuhri Snethlage, Elena Rampanelli, Kim Maasen, Noortje Walpot, Daniel H van Raalte, Max Nieuwdorp, Maarten R Soeters, Nordin M J Hanssen
Higher fibre and lower carbohydrate intake are associated with favourable CGM metrics in a cross-sectional cohort of 470 individuals with type 1 diabetes. Diabetologia (2024)
Mathias D G Van den Eynde, Alfons J H M Houben, Jean L J M Scheijen, Armand M A Linkens, Petra M Niessen, Nynke Simons, Nordin M J Hanssen, Yvo H A M Kusters, Simone J M P Eussen, Toshio Miyata, Coen D A Stehouwer, Casper G Schalkwijk
Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial. Diabetes, obesity & metabolism (2023)
Mathias D G Van den Eynde, A J H M Houben, J L J M Scheijen, A M A Linkens, P M Niessen, N Simons, Nordin M J Hanssen, Y H A M Kusters, S J M P Eussen, T Miyata, Coen D A Stehouwer, C G Schalkwijk
Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: a randomized double-blind placebo-controlled trial. Diabetes, obesity & metabolism (2023)
Douwe F de Wit, Nordin M J Hanssen, Koen Wortelboer, Hilde J Herrema, Elena Rampanelli, Max Nieuwdorp
Evidence for the contribution of the gut microbiome to obesity and its reversal. Science translational medicine 15 (723) (2023)
Reindert F Oostveen, Yannick Kaiser, Mia R Ståhle, Nick S Nurmohamed, Evangelos Tzolos, Marc Richard Dweck, Jeffrey Kroon, Andrew J Murphy, Damini Dey, Piotr J Slomka, Hein J Verberne, Erik S G Stroes, Nordin M J Hanssen
Atorvastatin lowers 68 Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes. Diabetologia (2023)
Coco M Fuhri Snethlage, Timothy James McDonald, Richard D Oram, Pleun de Groen, Elena Rampanelli, Alinda W M Schimmel, Frits Holleman, Sarah Siegelaar, Joost Hoekstra, Catherine B Brouwer, Filip K Krag Knop, C Bruce Verchere, Daniël H van Raalte, Bart O Roep, Max Nieuwdorp, Nordin M J Hanssen
Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes. Diabetes care (2023)
Nordin M J Hanssen, Nordin M J Hanssen, Jean L J M Scheijen, Marjo Van de Waarenburg, Hendrik Gremmels, Coen D A Stehouwer, Marianne C Verhaar, Miranda T Schram
Plasma Methylglyoxal Levels Are Associated With Amputations and Mortality in Severe Limb Ischemia Patients With and Without Diabetes. Diabetes care 44 (1) (2020)
Nordin M J Hanssen, Karin Am Jandeleit-Dahm
Dipeptidyl peptidase-4 inhibitors and cardiovascular and renal disease in type 2 diabetes: What have we learned from the CARMELINA trial? Diabetes & vascular disease research 16 (4) (2019)